CredibleX | $55,000,000 | (Dec 18, 2024)
Retellio | $1,300,000 | (Dec 18, 2024)
Chargezoom | $11,500,000 | (Dec 18, 2024)
Certified by Founder
Lodge
Bryleos
start up
United States
- Johnson City, Tennessee
- 14/06/2023
- Seed
- $5,000,000
Early clinical stage therapeutics company developing BNAD101, a patent-pending oral composition of NAD+ clinically proven to increase intracellular NAD+. BNAD101 is a potential high-value medicine to treat challenging and costly neurological disorders.
In 2022, the Company completed its double-blind, placebo-controlled proof of concept study at the Institute of Systems Biology. The study of 60 healthy adults demonstrated BNAD101 had a 52% increase in intracellular NAD levels against placebo within just 5 days, effectively validating the potential of BNAD101 in treating not only chronic neurological conditions but conditions were swift response is critical.
Bryleos: More Life While Living
- Industry Biotechnology Research
- Website https://bryleos.com/
- LinkedIn https://www.linkedin.com/company/bryleos/
BILT Incorporated | $21,000,000 | (Dec 18, 2024)
Fluid Biomed Inc. | $27,000,000 | (Dec 18, 2024)
FastWave Medical | $19,000,000 | (Dec 18, 2024)
Prequel.dev | $3,300,000 | (Dec 18, 2024)
Mili | $2,000,000 | (Dec 18, 2024)
Stand | $30,000,000 | (Dec 18, 2024)
Anatomy Financial | $19,000,000 | (Dec 18, 2024)
pagent.ai | Undisclosed Amount | (Dec 18, 2024)
Slip Robotics | $28,000,000 | (Dec 18, 2024)
Twill | $1,400,000 | (Dec 18, 2024)